The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapies against this neoplasia have a high percentage of failure, associated with the survival of self-renewing glioblastoma stem cells (GSCs), which repopulate treated tumors. In addition, despite new radi...
Main Authors: | Vincenzo Mattei, Francesca Santilli, Stefano Martellucci, Simona Delle Monache, Jessica Fabrizi, Alessandro Colapietro, Adriano Angelucci, Claudio Festuccia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/8/3863 |
Similar Items
-
Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression
by: Kun Liu, et al.
Published: (2021-05-01) -
Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
by: Xuejia Tang, et al.
Published: (2021-07-01) -
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
by: Giovanni Luca Gravina, et al.
Published: (2019-03-01) -
Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth
by: Hany E. Marei, et al.
Published: (2019-01-01) -
Stem cell-based therapy treating glioblastoma multiforme
by: Banafshe Abadi, et al.
Published: (2021-03-01)